Trademark Overview
On Thursday, November 9, 2023, a trademark application was filed for ABILETOS with the United States Patent and Trademark Office. The USPTO has given the ABILETOS trademark a serial number of 98263086. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, June 6, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The ABILETOS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain